127 related articles for article (PubMed ID: 38866914)
21. Pro-Inflammatory Diet Is Correlated with High
Rocha IMGD; Torrinhas R; Fonseca D; Lyra CO; de Sousa Alves Neri JL; Balmant BD; Callado L; Charlton K; Queiroz N; Waitzberg DL
Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836432
[TBL] [Abstract][Full Text] [Related]
22. A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease.
Gacesa R; Vich Vila A; Collij V; Mujagic Z; Kurilshikov A; Voskuil MD; Festen EAM; Wijmenga C; Jonkers DMAE; Dijkstra G; Fu J; Zhernakova A; Imhann F; Weersma RK
Gut Microbes; 2021; 13(1):1943288. PubMed ID: 34313538
[TBL] [Abstract][Full Text] [Related]
23. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
[TBL] [Abstract][Full Text] [Related]
24. Positive Correlation of Fecal Calprotectin With Serum Antioxidant Enzymes in Patients With Inflammatory Bowel Disease: Accidental Numerical Correlation or a New Finding?
Vaghari-Tabari M; Moein S; Qujeq D; Kashifard M; Hajian-Tilaki K
Am J Med Sci; 2018 May; 355(5):449-455. PubMed ID: 29753375
[TBL] [Abstract][Full Text] [Related]
25. Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels.
Hämäläinen A; Sipponen T; Kolho KL
World J Gastroenterol; 2011 Dec; 17(47):5166-71. PubMed ID: 22215940
[TBL] [Abstract][Full Text] [Related]
26. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y
J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593
[TBL] [Abstract][Full Text] [Related]
27. Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease.
Hertz S; Anderson JM; Nielsen HL; Schachtschneider C; McCauley KE; Özçam M; Larsen L; Lynch SV; Nielsen H
Ann Med; 2024 Dec; 56(1):2338244. PubMed ID: 38648495
[TBL] [Abstract][Full Text] [Related]
28. New insights into the biological and clinical significance of fecal calprotectin in inflammatory bowel disease.
Amati L; Passeri ME; Selicato F; Mastronardi ML; Penna A; Jirillo E; Covelli V
Immunopharmacol Immunotoxicol; 2006; 28(4):665-81. PubMed ID: 17190742
[TBL] [Abstract][Full Text] [Related]
29. Fecal Calprotectin, Gut Inflammation and Spondyloarthritis.
Simioni J; Skare TL; Campos APB; Kotze L; Messias-Reason I; Ioshii SO; Nisihara R
Arch Med Res; 2019 Jan; 50(1):41-46. PubMed ID: 31101242
[TBL] [Abstract][Full Text] [Related]
30. The role of fecal calprotectin in investigating inflammatory bowel diseases.
Erbayrak M; Turkay C; Eraslan E; Cetinkaya H; Kasapoglu B; Bektas M
Clinics (Sao Paulo); 2009 May; 64(5):421-5. PubMed ID: 19488608
[TBL] [Abstract][Full Text] [Related]
31. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
[TBL] [Abstract][Full Text] [Related]
32. Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease.
Broglie L; Rademaker A; Galvin J; Ray A; Tse WT; Duerst R; Schneiderman J; Kletzel M; Chaudhury S
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):169-174. PubMed ID: 29397331
[TBL] [Abstract][Full Text] [Related]
33. Inflammation, Genetics, Dysbiosis, and the Environment: New Paradigms for Diagnosis in Complex Chronic Gut Syndromes.
Walker MM
J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S4-5. PubMed ID: 27622361
[TBL] [Abstract][Full Text] [Related]
34. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
35. Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies.
Heilmann RM; Berghoff N; Mansell J; Grützner N; Parnell NK; Gurtner C; Suchodolski JS; Steiner JM
J Vet Intern Med; 2018 Mar; 32(2):679-692. PubMed ID: 29460444
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
Yang Z; Clark N; Park KT
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
[TBL] [Abstract][Full Text] [Related]
37. Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children: A Meta-analysis of Individual Patient Data.
Holtman GA; Lisman-van Leeuwen Y; Day AS; Fagerberg UL; Henderson P; Leach ST; Perminow G; Mack D; van Rheenen PF; van de Vijver E; Wilson DC; Reitsma JB; Berger MY
JAMA Pediatr; 2017 Oct; 171(10):984-991. PubMed ID: 28806445
[TBL] [Abstract][Full Text] [Related]
38. Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial.
Scaioli E; Belluzzi A; Ricciardiello L; Del Rio D; Rotondo E; Mena P; Derlindati E; Danesi F
Trials; 2019 Jun; 20(1):327. PubMed ID: 31171016
[TBL] [Abstract][Full Text] [Related]
39. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.
Konikoff MR; Denson LA
Inflamm Bowel Dis; 2006 Jun; 12(6):524-34. PubMed ID: 16775498
[TBL] [Abstract][Full Text] [Related]
40. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
